Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


BISPECIFIC T-CELL ENGAGING ANTIBODIES FOR CANCER THERAPY

  • In: A7 - Cancer immunotherapy: using drugs and cells to exploit our immune systems on Friday, 2 October 2015, 09:00-12:00
  • At: Düsseldorf (Germany) (2015)
  • Type: Presentation
  • By: WOLF, Andreas (Amgen Research Munich, München, Germany)
  • Co-author(s): Andreas Wolf
  • Abstract:

    BiTE™ antibodies are single-chain bispecific antibody constructs with specificity for CD3 on T cells and a selected surface antigen on target cells. By transiently bridging T cells and cancer cells, BiTE™ antibodies are capable to fully activate T cells and to mount a polyclonal T cell response that is no longer restricted by T cell receptor

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses